ClinicalTrialsFinder

EGFR/HER2 Exon 20 Insertion Mutation Clinical Trials in Cheongju-si

1 recruitingCheongju-si, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Non-small Cell Lung CancerNSCLCEGFR/HER2 Exon 20 Insertion Mutation
Pierre Fabre Medicament345 enrolled24 locationsNCT06043817